Mary Caitlin King

22PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)Cancer diagnosisModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 09, 2025
Recurrence Incidence and Optimal Surveillance After Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Mucinous Appendix Cancer.

V Kovalik, A Sardi, M C King

|Aug 26, 2025
Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgery.

Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King

|Jul 01, 2025
The Effect of Prior Nondefinitive Surgery on Perioperative Outcomes and Survival in Mucinous Appendix Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Sergei Iugai, Vadim Gushchin, Mary C King

|Apr 01, 2024
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).

Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King

|Dec 28, 2023
Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix.

Felipe Lopez-Ramirez, Armando Sardi, Mary Caitlin King

|May 31, 2022
Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPEC.

Ekaterina Baron, Armando Sardi, Mary Caitlin King

Pageof 4

Frequent Collaborators

21 joint publications

Armando Sardi

19 joint publications

Vadim Gushchin

9 joint publications

Andrei Nikiforchin

8 joint publications

Ekaterina Baron